An exhaustive overview of floating drug delivery system by Mukherjee, Lucky et al.
Mukherjee  et al                                                                                                Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):900-906 
ISSN: 2250-1177                                                                                  [900]                                                                                      CODEN (USA): JDDTAO 
Available online on 15.06.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                           Review Article 
An exhaustive overview of floating drug delivery system 
Lucky Mukherjee1*, Srikanta Chandra2, Bijayan Mukherjee3, Mithun Bhowmick 1 
1. Bengal College of Pharmaceutical Sciences and Research, Department of Pharmaceutics, Durgapur. 713363, West Bengal, India 
2. Gupta College of Technological Sciences, Depart of Pharmacology , Asansol , 713301 , West Bengal, India 
3. NRS Medical College, Kolkata, West Bengal, India 
 
ABSTRACT 
The purpose of writing this review is to narrowing down on floating drug delivery systems (FDDS) and to compile the current l iterature with 
special focus on the principal mechanism of floatation to ameliorate gastric retention. The current amelioration of FDDS including the 
physiological and formulation variables affecting gastric retention approaches to design single unit and multiple unit floati ng systems, and a 
plethora and formulation aspects are covered in detail. This review also summarizes the in vitro technique and in vivo studies to evaluate the 
performance and application of floating systems and applications of these systems. These systems are useful to several plight s encountered 
during the amelioration of a pharmaceutical dosage form. 
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INTRODUCTION 
In the modern era different routes of administrations having 
varieties of nuance but oral route administration has 
tremendous advancement in drug delivery system. However, 
oral routes have different advantages rather than any other 
route   . This route got success because gastrointestinal 
physiology offers more flexibility in dosage form design than 
other routes. The gastric emptying of dosage forms is an 
extremely variable process and ability to prolong and 
control the emptying time is a valuable asset for dosage 
forms that reside in the stomach for a longer period of time 
than conventional dosage form. Drug absorption from 
gastrointestinal tract is a complexable procedure 1.  It is 
widely acknowledged that the extent   of gastrointestinal 
tract drug absorption is related to contact time with the 
small intestine mucosa. Gastro retentive drug delivery 
systems are the system which are   retained in the stomach 
for a longer period of time and thereby improve the 
bioavailability of drugs which are absorbed from upper 
gastro intestinal tract.  The drug bioavailability of 
pharmaceutical dosage forms is influenced by various 
factors.  However, pivotal point is that   gastric residence 
time another factors of these dosage form. The process of 
gastric emptying   from stomach to intestine generally lasts 
from a few mins to 12 hrs.  This variability leads to an 
unpredictable bioavailability of an orally administered 
dosage form. FDDS have a bulk density less than gastric 
fluids and so remain buoyant in the stomach without 
affecting the gastric emptying rate  for a prolonged period of 
time.2 However ,  the drug is released in this system very 
slowly after release   of drugs the residual system  is emptied 
from the stomach.  This results in increased GRT and better 
control of fluctuations in plasma drug concentration.3  
Basic Gastrointestinal Tract Physiology:  
The digestive system are composed of the gastrointestinal 
tract /digestive tract/gut three pairs of salivary glands , the 
liver and another one is that pancreas. Different parts of the 
GI tract  are oral cavity , pharynx , oesophagus , stomach , 
duodenum , jejunum , ileum , caecum , ascending colon , 
transverse colon , descending colon , sigmoid colon , rectum , 
and another pivotal component is that anal canal. 
Stomach is the sac like dialated part of the gut in between 
oesophagus and duodenum. Its capacity may vary from 50 
ml to 5 litre. The gut wall composed of four layers but it has 
additional muscle layer (the inner most oblique layer) . The 
stomach is divided into three gyners first one is fundus, 
second thing that is body rest pylorus. The oesophagus end 
of the stomach is called cardiac and is guarded by a 
physiological sphincter .The pylorlic sphincter is situated in 
between the stomach and the duodenum. The pyloric 
sphincter is formed by the thickening of the circular layer of 
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muscles. The mucous membrane of stomach is thick and is 
thrown into folds called gastric rugae seen only in empty 
stomach .This arrangmentys helps to accommodate extra 
volume of food without stretching the mucous membrane. 
The lining cells of the mucous membrane are of simple 
columner type which secrets mucin and arte covered by a 
thick layer of gastric mucin .The glands are situated within 
the mucous membrane in groups of 2 to 7 which together 
communicate with the gastric lumen through the gastric 
pits.4,5 
Gastric glands:  
These glands are of three types first one is cardiac second is 
fundic and rest body, pyloric glands. The cardiac glands are 
small in number , situated in the cardiac end and secrete 
mainly mucin .The glands in the fundus and body are highest 
in number and secrete the acidic juice .The pyloric glands 
are again of mucous types. Atypical acid secreting gland is 
tubular and straight .Each gland is divided into three parts 
neck, body and another is that base. The junction of a gland 
with the gastric pit is called isthmus .The cell lining the 
glands are of the following types isthmus cell, neck cell, 
oxyntic cell, another one is chief cell. The isthmus and neck 
cell are secrete mucin .The neck cell are common types 
called mother cell. These cells divided and differentiate to 
produce both of the surface epithelium as well as the cells of 
the glands proper each cells takes 2 to 3 days to mature and 
function and are ultimately desquamated.6,7 
Chief cells or peptic cells: 
These cells secrete pepsinogens and are the sources of 
rennin in calves and gelatinase in pigs. These are situated in 
the wall of the glands near the base and contain zymogen 
granules of pepsinogens. 
Oxynntic cells or parietal cells:  
These are situated mainly towords the neck of the glands 
and secrete hydrochloric acids and the intrinsic factors 
.These cells have an extensive microcanalicular system 
which communicates with the lumen of the glands by a 
canaliculus . In resting state of the cell part of this 
microcanalicular system is converted into innumerable 
tubulovesicular structures formed of smooth membrane 
.These vesicles are fused with the microcanalicular system 
when the cell is stimulated to secrete HCL. 
Gastric glands:  
Gastric glands also contain many other types of cells .The 
amine precursor uptake and decarboxylation cells (APUD 
cells) form the important group which secrete different GIA 
hormones .Mast cells secrete histamine .Argentaffin cells are 
yhere to secrete serotonin . There are also cells which 
secrete various local hormones like bombesin , somatostatin 
, glucagon etc.  
G cells: 
The G cells of the stomach are present in the pyloric glands 
and secrete gastrin .These cells are triangular or conical in 
shape with the narrow apex towords the lumen. Several 
microvilli project from the apex .Gastrin is stored in the 
granules inside the cells .The cells release gastrin through 
the basal side when they receive stimuli from the apical side 
through the microvilli. 
Mechanism of action of HCL Secretion: 
In the microcanalicular system of the oxyntic cells there are 
proton pumps H+K+ATPase. On stimulation of the cell the 
tubulovesicles fuse with the microcanaliculi to increase 
surface area along with the number of proton pumps in it. 
These proton pumps actively transport H+ into the 
microcanaliculi from the cytoplasm of the oxyntic cell in 
exchange of K+ after consumption of ATP. Chloride ions are 
transported through the chloride channels in the micro 
canalicular membrane and K+ follows. These H+ and CL- 
secreted into the microcanaliculi now form the HCL. The CL 
comes from the plasma through the basal side of the cell via 
CL- HCO3- exchange . H+ is produced in the cytoplasm from 
ionisation of water (H2O → H+  + OH-) For each H+  ,one OH- 
is produced which is highly toxic and is neutralised by H+ 
produced within the cells from hydration of CO2 in presence 
of carbonic anhydrase.8 
 Intestinal secretion :  
It is the secretion produced by the glands in the small 
intestine. It is more a transduate than a secretion by the 
glands .The glands involved are called crypts of Lieberkuhn 
.These glands are produced by outward extension of the 
surface mucous membrane or as depressions in between the 
intestinal villi. These are simple tubular glands lined by 
columner cells. The villi are finger like projections situated 
all over the mucous membrane of the small intestine but are 
more in jejunum than in ileum .The villi are lined externally 
by a layer of columnar cells also called enterocytes., the, 
main lining epithelium of the intestine .Each villus is about 
0.5 to1 mm in length .The core of the villus contains 
connective tissue, blood vessels, smooth muscles fibres and 
a lymphatic channel. The blood vessels form loops through 
which the arterial blood goes towards the tip and then 
returns as venous blood .The lacteal joins the lymphatic 
system .This types of arrangements in lymph and blood flow 
in the villi is very much helpful for absorption .The 
enterocytes have microvilli (brush border) on the luminal 
side which is covered by a layer of glycocalyx . The cell 
membrane in the brush border contains various enzymes 
needed for digestion. The villi and microvilli both of them 
increase the surface area of the mucous membrane of the 
small intestine and thus aid the process of absorption. The 
cells lining the crypts of Lieberkuhn which elaborate the 
succus entericus, differentiate into enterocytes and 
gradually move up the villi .One such cell is the goblet cell 
which secretes mucus. The paneth cells secrete bacteriolytic 
enzymes. Enterochromaffin cells secrete serotonin which 
probably cause intestinal secretion and movement.Another 
types of cells are present that is M cells or microfold cells. It 
is an antigen presenting cell and present antigens to the 
lymphoid cells in the gut to cause secretory immunity.9  
Gastric empty rate : 
 A gastric empty rate occurs during fasting condition as well 
as fed states. The pattern of motility distinct in the 2 states. 
During the fasting in condition indigestive series of electrical 
events takes place which cycles both through stomach 
intestine every 2 to 3 hours . This is called indigestive mylo 
electric cycle. This cycle is divided into 4 gyners . 
Phase 1: it’s also called basal phase .However lasts from 40 
to 60 mins with rare contraction. 
Phase 2: This phase is also called preburst phase. However 
lasts for 40 to 60 mins with intermittent action potential and 
contractions In this phase progresses the intensity and 
frequency are also increase gradually.  
Phase 3: This is also called burst phase. However lasts for 4 
to 6 mins . It includes intense and regular contraction for 
short period of time.  
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Approaches to gastric retention:  
In the modern era different types of system have been 
developed to increase the gastric retention time of dosage 
forms by employing range of concepts. The basic 
classification of this system has been explaned briefly under. 
1. Floating drug delivery system:  This system have low 
density and so float over the gastric contents.  
2. Bioadhesive system : This system is very important  
because they bind  with stomach mucosa and hence 
enable to localize retention of the system  
3. Swelling and expanding: Such system absorbs water 
and hence enlarged size. 
4.  High density system: They remain in the stomach for 
longer period of time by sedimenting to the folds of the 
stomach. 
Floating drug delivery system: 
Floating drug delivery system (FDDS) or hydrodynamically 
controlled system which have a bulk density less than 
gastric fluids and because of this these systems remains 
buoyant (3-4hrs) for a prolonged of time in the stomach 
without affecting the gastric emptying rate. 
Advantages of floating drug delivery system: 
1.Floating dosage forms such as tablets or capsules will 
remains in the solution for prolonged time event alkaline 
PH of the intestine. 
2. FDDS are advantageous for drugs meant for local action in 
the stomach. eg: Antacids. 
3. FDDS dosage forms are advantageous in case of vigorous 
intestinal movement and in diarrhoea to keep the drug in 
floating condition in stomach to get a relatively better 
response. 
4. Acidic substance like aspirin causes irritation on the 
stomach wall when come in contact with it hence FDDS 
formulations may be useful for the administration of 
aspirin  and other similar drugs. 
5. The FDDS are advantageous for drugs absorbed 
through the stomach . eg: Ferrous salts , antacids. 
6. Slow release of the drug into the body minimizes the 
counter activity leading to higher drug efficacy. 
7. FDDS reduces the drug concentration fluctuation over 
a critical concentration and thus enhances the 
pharmacological effects and improves the clinical 
outcomes. 
8. Retention of drug in GRDF  at stomach minimizes the 
amount of drugs that reaches the colon and hence 
prevents the degradation of drug that degraded in the 
colon. 
9.  A floating dosage form is a widely  accepted  approach 
especially for drugs which have limited absorption 
sites in upper small intestine.10 
Disadvantages of Floating drug delivery system:  
1.  These systems require a high level of fluid in the 
stomach for drug delivery to float and work efficient – 
coat. 
2. Not suitable for drugs that have solubility or stability 
problem in GIT. 
3. Drugs such as Nifedipine ( calcium channel blocker)  
which is well absorbed  along the entire GIT and which 
undergoes first pas metabolism , may not be desirable. 
4. Drugs which are irritant to gastric mucosa are also not 
desirable  or suitable. 
5. The  drug substance that are unstable in the acidic 
environment of the stomach  are not suitable  
candidates to be incorporated  in the systems. 
6. The dosage form  should be administered with a full 
glass of water( 200- 250 ml) 
7. These system do not offer significant advantages over 
the conventional dosage forms for drugs , which are  
absorbed throughout the gastrointestinal tract.11 
Drug Candidates Suitable for Floating drug 
delivery systems: 
In general, appropriate candidates for CR-GRDF are 
molecule that have poor  colonic absorption but are 
characterized   by better absorption properties  at the upper  
part of the  GIT :  
 Narrow absorption  window in GI tract ,  e.g , riboflavin  
and levodopa 
 Primarily absorbed from stomach  and upper part of GI 
tract  , e.g: calcium supplement , cholrdiazepoxide and 
cinnarazine. 
 Drugs that act locally  in the stomach , e.g : H2  receptor 
antagonists , antacids  and misoprostol. 
 Drugs that degrade in the colon, e.g :  ranitidine HCL 
and metronidazole.  
 Drugs that disturb normal colonic bacteria , e.g : 
amoxicillin  trihydrate.12,13 
 Mechanism of Floating Systems: 
 Various attempts have been made to retain the dosage form 
in the stomach as a way of increasing the retention time. 
These attempts include introducing  floating dosage forms ( 
gas generating systems and swelling or expanding  systems ) 
, mucoadhesive system , high density systems , modified 
shape systems , gastric emptying delaying devices  and co-
administration of gastric emptying  delaying drugs . Among 
these the floating dosage forms are the most commonly 
used. Floating  drug delivery systems ( FDDS)  have a bulk 
density less than gastric fluids and so remain buoyant in the 
stomach  without affecting the gastric emptying rate for a 
prolonged period  of time. While the system is floating on the 
gastric contents the drug is released slowly at the desired 
rate from the system . After release of drug , the residual  
system is eliminated from the stomach . This results in an 
increased GRT and a better control of the fluctuations in 
plasma drug concentration. However , besides a minimal 
gastric content needed  to allow the proper  achievement of 
the buoyancy retention effect , a minimal level of floating 
force ( F)  is also required to maintain the buoyancy   of the 
dosage form  on the surface of the meal. To measure the 
floating force kinetics, a novel apparatus for determination 
of  resultant weight has been reported in the literature.14,15  
F = F buoyancy – F gravity  = ( Df- Ds ) g v  
Where ,  F = total vertical force  
DF = fluid  density 
Ds =  object density 
V= volume 
G = acceleration due to gravity 
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Drugs Unsuitable for Gastric Retention: 
1.  Drugs that have very limited acid solubility  e.g .  
phenytoin  
2. Drugs that suffer  instability in the gastric environment 
e.g  erythromycin . 
3. Drugs intended for selective release  in the colon e.g   5 
amino salicylic acids and corticosteroids . 
Factors Affecting Gastric Retention: 
The gastric retention  time ( GRT)  of dosage form  is 
controlled by several factors that affect their efficacy as a  
gastroretentive system . 
Density: GRT is a function of dosage form buoyancy that is 
dependent on the density.  
Size: Dosage form units with a diameter of  more than 9.5 
mm  are reported to have an increased GRT. 
Shape of Dosage form : Tetrahedron and ring- shaped 
devices with a flexural  modulus of 48 and 22.5 kilopounds 
per square  inch ( KSI)  are reported to have better GRT . 90 
%  to 100 %  retention at 24 hrs compared with other 
shapes. 
Single or Multiple Unit Formulation : Multiple unit  
formulation shows a more   predictable release profile and 
insignificant  impairing of performace due to failure of units , 
allow  coadministration  of units with different release 
profiles  or containing incompatible substances and permit a 
larger margin  of safety against dosage form  failure 
compared  with single unit dosage forms. 
 Fed or Unfed State:  Under fasting conditions , the GI 
motility is characterized by  periods of strong motor activity  
or the migrating myoelectric  complex ( MMC)  that occurs 
every 1.5 to 2 hrs . The MMC  sweeps undigested material  
from the stomach  and if the timing  of administration  of the 
formulation coincides with that of  the MNC , the GRT of the 
unit can be expected to be very short. However , in the fed 
state , MMC is delayed and GRT is considerably  longer .  
Nature of Meal: Feeding of indigestible polymers or fatty 
acids salts  can change the motility pattern of the stomach  to 
a fed state , thus  decreasing the gastric  emptying rate and 
prolonging drug release. 
 Caloric Content: GRT can be increased by four to 10 hours 
with a meal that is high  in proteins and fats . 
 Frequency of Feed: The GRT can increase by over 400 
minutes when successive meals are given compared with a 
single meal due to the low frequency of MNC. 
Gender : Mean ambulatory  GRT  in meals ( 3.4 ± 0.6 hours)  
is less compared with their age  and race –matched female 
counterparts (4.6 ± 1.2 hours ) , regardless of the weight , 
height and body surface . 
Age: Aged people, especially those over 70, have a 
significantly longer GRT. 
Posture: GRT can vary between supine and upright 
ambulatory states  of the patients. 
Concomitant Drug Administration: Anticholinergics like 
Atropine and propantheline , opiates like codeine and 
prokinetic  agent like Metoclopramide and Cisapride. 
Biological Factors: Diabetes and Crohn’s disease . 1.Single 
unit 2 . Multiple unit16,17,18 
Approaches to Design Floating Dosage: 
Single Unit Dosage Form  
In low density: Approach the globular shells apparently  
having lower density  than that of  gastric fluids can be used 
as a carrier for drug for its controlled release. A buoyant 
dosage form can also be obtained  by using  a fluid –filled 
system that floats in the stomach . In  coated shells 24 
popcorn , poprice and  polystyrol have been used as drug 
carriers . Sugar polymeric materials such as   methacrylic 
polymer and cellulose acetate phthalate have been used to 
undercoat these shells. These are further coated with a drug 
polymer mixture . The polymer  of choice can be either ethyl 
cellulose or hydroxypropyl  cellulose depending on the type 
of release desired .19 Finally the product floats on the gastric 
while releasing the drug gradually over a prolonged 
duration . 
Fluid Filled Floating Chamber:    
Type of dosage forms includes incorporation of a gas  filled 
floatation chamber into  a microporus component that 
houses a drug reservoir . Apertures or openings are present 
along the top and bottom walls through which  the 
gastrointestinal tract fluid enters to dissolve  the drug .The 
other two walls in contact with the fluid are sealed so that 
the undissolved  drug remains therein. The fluid present 
could be air ,  under partial vacuum or any other  suitable 
gas , liquid or solid having  an appropriate specific gravity 
and an inert behaviour . The device  is of swallowable size , 
remains afloat within the stomach for a prolonged time , and 
after the complete release the shell disintegrates passes off 
to the intestine and is eliminated.20   
Hydrodynamic Balanced System:  
These are designed to prolong the stay of the dosage form in 
the gastrointestinal tract and aid  in enhancing the 
absorption . Such systems are best suited  for drugs having a 
better solubility  in acidic environment and also for the 
drugs having specific site of absorption  in the upper part of 
the small intestine . To remain  in the stomach  for a 
prolonged period  of time the dosage form  must have a bulk 
density of less than 1. It should stay in the stomach , 
maintain its structural integrity  and release drug constantly 
from the dosage form .21 
Multiple Unit Dosage Form: 
 The purpose of designing multiple unit dosage form  is to 
develop a reliable formulation  that has all the advantages  of 
a single unit form and also is devoid of any of the drawback 
of single unit formulations. Single unit  formulations are 
associated with problems such as sticking together or being 
obstructed  in gastrointestinal tract , which may have a 
potential  danger of producing irritation .Multiple unit 
systems  avoid the all or none gastric emptying nature  of 
single unit systems. It reduces the intersubject  variability in 
absorption and the probability  for dose damping is lower 
.Microspheres have high  loading  capacity and many 
polymers have been used such as albumin , gelatine , starch , 
polymethacrylate, polyacrylamine, and polyalkylcyano-
acrylate. Spherical polymeric microsponges , also referred to 
as microballoons have been prepared .Microspheres have a 
characteristic  internal hollow structure and show an 
excellent in vitro floatability .22 
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    Classification of Floating Drug Delivery System     
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                                                          Gas generating system                                  Colloidal gel barrier system 
                                                          Volatile liquid containing system              Alginate beds 
                                                                                                                                        Hollow microspheres/ Microballoons 
                                                                                                                                        Intragastric Floating Drug Delivery 
                                                                                                                                        Device / Microporous compartment system 
 
Effervescent Floating Dosage Forms:  
These are matrix types of systems prepared with the help of 
swellable polymers (methyl cellulose and chitason)  and 
various effervescent compounds ( sodium bicarbonate , 
tartaric acids , and citric acid) .They are formulated  in such a 
way that when come in contact with acidic gastric contents , 
CO2 liberate and gas entrapped in swollen  hydrocolloids 
which provides buoyancy to the dosage  forms . 
Gas Generating Systems: 
These buoyant delivery systems utilize effervescent  
reactions between carbonate /bicarbonate salts and citric / 
tartaric acids  to  liberate CO2 which gas entrapped in the 
gellified hydrocolloid layer of the systems  thus decreasing 
its specific gravity and making it to float  over chime. 
Volatile Liquid Containing Systems: 
The GRT of a drug delivery  system can be sustained by 
incorporating an inflatable chamber , which contains a liquid 
(like ether, cyclopentane)  that gasifies at body temperature 
to cause the inflation of the chamber in the stomach .The 
device may also consist of a bio- erodible plug made up of 
PVA , polyethylene  etc . that gradually dissolves and causing 
the inflatable chamber to release gas and collapse after a 
predetermined time to permit the spontaneous ejection of 
the inflatable systems from the stomach .23 
Non –effervescent Floating Dosage Forms: 
The non-effervescent FDDS works on the mechanism of 
polymer swelling , bioadhesion of the polymer to mucosal 
layer of GI tract .The  most common used excipients for the 
preparations of non-effervescent FDDS are gel  forming or 
swellable  cellulose type hydrocolloids , polysaccharides and 
matrix forming polymers like  polycarbonate, , polyacrylate , 
polymethacrylate and polystyrene . The formulation method  
includes simple approach of thoroughly mixing of the drug 
and the gel –forming  hydrocolloid . After oral 
administration this dosage form swells in contact with 
gastric fluids and attains  bulk density of less than 1. The air 
entrapped within the swollen matrix imparts buoyancy to 
the dosage form ,so  formed swollen gel- like  structure 
release of drug through the gelatinous mass.24 
Colloidal Gel Barrier Systems: 
A system that contains drug with  gel – forming 
hydrocolloids meant to remain buoyant  on the stomach 
content. This prolongs GRT and maximizes the amount of 
drug  that reaches its absorption sites in the solution  form 
for ready absorption. This system incorporates  a high level 
of one or more gel forming  highly swellable  cellulose type 
hydrochlorides , e.g : HEC , HPMC, NaCMC , polysacchacaries  
and matrix forming polymer such as  polycarbophil , 
polyacrylates  and polystyrene , incorporated either in 
tablets or in capsule. On coming in contact with gastric fluid , 
the hydrocolloid in the system hydrates and forms  a 
colloidal gel barrier around the gel surface. The air trapped 
by the swollen polymer maintains  a density less than unity 
and confers buoyancy  to this dosage forms.25 
Alginate beads: 
Multi –unit floating dosage forms have  been  ameliorates 
from freeze- dried  calcium alginate. Spherical beads of 
approximately  2.5 mm in diameter can be  prepared by 
dropping sodium alginate solution into aqueous  solution of 
calcium chloride , causing the precipitation of calcium 
alginate . The beads are then  separated , snap- frozen in 
liquid  nitrogen , and freeze –dried at -40 degree  C for 24 hrs 
., leading to the formation  of a porous system , which can 
maintain a floating  force for over 12 hours.26  
 Hollow microspheres / Microballoons: 
It is prepared  by a novel emulsion solvent diffusion method 
. The ethanol / dichloromethane solution of the drug and an 
enteric acrylic polymer was poured into an agitated solution 
of poly Vinyl Alcohol( PVA) that was thermally controlled at 
40 degree C . The gas phase is generated in the dispersed  
polymer droplet by the evaporation of dichloromethane  
formed and internal cavity in the microsphere of the 
polymer with drug.27 
Intragastric / Microporous Compartment System: 
The system composed of a drug reservoir encapsulated in a 
microporous compartment  having pores  on top and bottom 
surfaces. The peripheral walls of the reservoir  compartment 
were completely sealed to prevent any physical contact of 
the undissolved drug with  walls of the  stomach. Novel 
levodopa gastro retentive  dosage form based on unfolding 
polymeric members which combines  extended dimensions 
with high rigidity. It was folded into  a large size gelatin 
capsules . In vitro studies showed  that unfolded form 
reached within 15 minutes after  administration and it was 
confirmed in vivo in beagle dogs. The unfolded form was 
maintained  for at least 2 hours. It was concluded that this 
narrow absorption window drugs. However , there  are 
possibilities of the polymeric films to get stuck  in the 
oesophagus causing extreme discomfort  to the patient  or 
drug related injuries and repeated  administration of rigid 
dosage form may result in gastric obstruction.28 
Application of Floating Drug Delivery System: 
Floating drug delivery offers several applications for drugs  
having poor bioavailability because of the narrow  
absorption window  in the upper part of the  gastrointestinal 
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tract .  It remains the dosage form at the site of absorption  
and thus enhances the bioavailability . These are 
summarized as follows: 
1. Sustained Drug Delivery: 
 HBS system can remain in the stomach for long periods and 
hence can  release the drug over a prolonged period of time . 
The problem of short gastric  residence time encountered 
with an oral CR formulation hence  can be overcome  with 
these systems . These systems have a bulk density of < 1 as a 
result of which they can  float on the gastric contents .These 
systems are relatively  large in size and passing from the 
pyloric opening is prohibited . Recently sustained release 
floating capsules  of nicardipine hydrochloride were 
developed and were evaluated in vivo. The formulation  
compared with commercially available MICARD capsules  
using rabbits. Plasma concentration time  curves showed  a 
longer duration for administration ( 16 hours)  in the 
sustained release floating capsules as compared  with 
conventional  MICARD capsules ( 8 hours) 
2. Site Specific Drug Delivery: 
These systems are particularly advantages for drugs that are 
specifically absorbed from stomach or the proximal part of 
the small intestine e.g : riboflavin  and furosemide ( K+ 
sparing diuretics) . However the pivotal point is that 
furosemide is primarily absorbed from the stomach followed 
by the duodenum. It has been reported that a monolithic 
floating dosage from with prolonged gastric residence time 
was developed and the bioavailability was increased .AUC 
obtained with the floating tablets was approximately 1.8  
times those of conventional furosemide tablets.  A bilayer – 
floating capsule was developed for local delivery  of 
misoprostol ,  which is a synthetic analog  of prostaglandin 
used as a protectant of gastric ulcers caused by 
administration of NSAIDs by  targeting slow delivery of 
misoprostol to the stomach , desired therapeutic  levels 
could be achieved and drug waste could be reduced. 
3. Absorption Enhancement:  
Drugs have poor bioavailability because of site – specific 
absorption  from the upper part of the gastrointestinal tract  
are potential candidates to be formulated as floating drug 
delivery  system , thereby maximizing their absorption . A 
significant increase in the bioavailability of floating dosage 
forms (42.9%) could be achieved as compared with 
commercially available   LASIX tablets (33.4%) and enteric –
coated LASIX –long product (29.5%). 
4. Enhanced Bioavailability: 
 The bioavailability of riboflavin CR-GRDF is significantly 
enhanced in comparison to the administration of non –CR-
GRDF polymeric formulations. There are several different 
processes, related to absorption and transit of the drug in 
the gastrointestinal tract, that act concomitantly to influence 
the magnitude of drug absorption. 
5. Enhanced first –pass biotransformation: 
In a similar fashion to the increased  efficacy of active 
transporters exhibiting capacity limited activity , the pre-
systemic metabolism of the tested  compound may be 
considerably increased when the drug is presented  to the 
metabolic enzymes (cytochrome p450, in particular CYP3A4 
)  in a sustained manner ,rather than by a bolus input. 
6. Sustained drug delivery/reduced frequency of dosing: 
For drugs with relatively short biological half-life ,sustained 
and slow input  from CR-GRDF may result in a flip –flop 
pharmacokinetics and enable reduced dosing frequency 
.This features is associated  with  improved patient 
compliance ,and thereby improves therapy. 
7. Targeted therapy for local ailments in the upper GIT: 
The prolonged and sustained administration of the drug 
from GRDF to the  stomach may be advantageous  for local 
therapy in the stomach and small intestine . By  this mode of 
administration ,therapeutic drug concentrations  may be 
attained locally while systemic concentration ,following  
drug absorption  and distribution , are minimal. 
8. Reduced fluctuations of drug concentration: 
Continuous input of the drug following CR-GRDF 
administration produces blood drug concentration  within a 
narrower range compared to the immediate  release dosage 
forms .Thus ,fluctuations in drug effects are minimized and 
concentration dependent  adverse effects that are associated 
with peak concentrations can be prevented .This feature is of 
special importance for drugs with a narrow therapeutic 
index. 
9. Imporved selectivity in receptor activation: 
Minimization of fluctuations in drug concentration also 
makes it possible to obtain certain selectivity in the elicited 
pharmacological effect of drugs that activate different types 
of receptors at different concentrations. 
10. Reduced counter –activity of the body: 
In many cases , the pharmacological response which 
intervenes with the natural physiological process provokes a 
rebound activity of the body that minimizes drug activity 
.Slow input  of the drug into the body was shown to 
minimize the counter activity  leading to higher drug 
efficacy.29,30 
CONCLUSION 
From this review we opined that drug absorption in gastro 
intestinal tract is highly variable procedure and prolonging 
the gastric retention of the dosage form. FDDS is better 
approach rather than any other drug delivery system to 
achieve gastric retention. This article give a lacunae 
overview   of the FDDS   as well as the main concept used to 
design the drug delivery system to achieve the prolong 
gastric retention. 
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